New Version of Gardasil Doubles Aluminum Content

Recently, the FDA approved a ‘new and improved’ version of Gardasil dubbed Gardasil 9 in which the amount of aluminum is more than double than in the original formulation. With that being said, Gardasil 9 also was approved without being consulted by the Vaccines and Related Biological Products Advisory Committee (VRBPAC) that ‘is responsible for reviewing and evaluating data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products.’

During the approval, a signed FDA letter by Marion Gruber who is the Director of Office of Vaccines Research and Review, stated that Gardasil 9 ‘did not raise concerns or controversial issues,’ thus was approved without examination by VRBPAC. The controversial issue at hand is that this new formula was approved with more than double the amount of aluminum content while there are numerous reports and data from adverse health effects related to the original formula.

With that being said, David A. Geier and Mark R. Geier, a father-son research team, published a study just two days before Gardasil 9 was approved, that found thousands instances of adverse events documented that was related to the original formula. In their study, they examined data from the Vaccine Adverse Event Reporting System (VAERS) with dates ranging from January 2006 to December 2012. Upon reviewing the database, they were pinpointing autoimmune adverse events (SAAEs) in women between the ages of 18 to 39 years old.

The two researchers analyzed the data and found 22,011 adverse events in the VAERS database from women who were administered Gardasil. These women suffered the following SAAEs:

  • Guillain-Barre Syndrome
  • Gastroenteritis
  • Systemic Lupus Erythematosus,
  • Arthritis
  • Vasculitis
  • Alopecia
  • Central Nervous System Conditions

They suggest that there is significant evidence of a causal relationship between Gardasil and the resulting SAAEs. Not only does their study document many adverse events following the administration of Gardasil, but other CMSRI funded researchers have published reports of similar findings in which women experience adverse reactions after receiving doses of Gardasil and some reactions have resulted in deaths. This new study highlights the strong links between this vaccine and certain autoimmune adverse reactions which previously have been linked to neurotoxic aluminum used in Gardasil. Doubling the amount of aluminum without conducting further research on how it may affect the already significant rate of adverse reactions is fraud and negligence on behalf of health agencies responsible for ensuring the safety of the vaccines recommended, and in some cases, mandated for use.

Other studies have dismissed the increase in reported autoimmune reactions after Gardasil, claiming their appearance after receiving the vaccine is only a “coincidence.” In that case, there has been an epidemic increase of “coincidence” since Gardasil has been approved, especially “severe coincidences.”

As Gardasil 9 is released and marketed as the “new and improved” version of Gardasil, health-conscious consumers should take note of the additional toxic ingredients in the formula, which includes more than double the amount of aluminum adjuvant that has already demonstrated harm at lower levels, as well as other potentially harmful ingredients.

Based on the results of this and several other independent studies, Gardasil has demonstrated risks that exceed the benefits, and this should make parents think twice about the new vaccine which contains more than double the amount of aluminum.

 

Read More

Claire Dwoskin Interviewed At AutismOne Conference

In July 2014, the annual AutismOne Conference was held at the InterContinental Chicago O’Hare Hotel in Rosemont, IL where Claire Dwoskin and Dr. Stephanie Seneff were in attendance. AutismOne is the premier networking center of the autism advocacy and science community, where researchers, doctors and parents come together to share support and ideas with each other. While Mrs. Dwoskin and Dr. Seneff participated in various engagements, Mrs. Dwoskin was interviewed by an AutismOne host, Leslie Carol Botha, who brought to light the important mission behind CMSRI.

During the interview, Dwoskin explains that the foundation was created to address various eroding national health issues that include conditions like autism, Alzheimer’s disease, autoimmune diseases, food allergies, asthma and many others. With that being said, 54 percent of all children today have some type of chronic health condition, which also includes obesity. Additionally, 90 percent of those children with chronic health conditions continue to suffer from these conditions beyond the age of 18. The U.S. healthcare system was not designed to care for such large numbers of chronically ill and disabled children who will remain in need of daily use medicines or therapies throughout their lifetimes. In decades past, people did not become heavy users of the healthcare system until after the age of 50; now, we are seeing children being as heavy or heavier users of the healthcare system than was previously documented.

With this in mind, the chronic illness and disability epidemic puts a debilitating burden on parent’s shoulders in terms of financial stability. Some parents have to stay home to care for their child 24/7, and to add to this economic penalty, there is the constant need for multiple doctors’ appointments. The medical bills pile up, and chronic health conditions spiral into many issues that can affect the whole family. Parents are increasingly despairing of the emotional and financial toll these health conditions exact on their marriages and family life, and are resorting to drastic and desperate actions such as faced by Alex Spourdelakis’ parents. His tragic story is poignantly told in the documentary film, “Who Killed Alex Spourdelakis.” Additionally, parents have collectively shared their stories of suffering through the #hearthiswell campaign.

Addressing the causal factors of chronic health conditions is CMSRI’s mission, because raising awareness of the causal factors so that they can be avoided could potentially reduce the number of children being diagnosed with these debilitating and often deadly conditions.

CMSRI funds research on the causal factors underlying chronic health conditions, because it’s just not enough to simply treat and medicate symptoms; we need to find out the root causes to prevent their occurrence . With over 900 cases, studies and research reports on aluminum toxicity alone, CMSRI has targeted, through a strategic research agenda, an understanding of how aluminum affects the body. This large body of research supporting aluminum’s role in the development of chronic health conditions will be greatly enhanced by the results of this research, which will be peer reviewed and submitted for publication. This research is independent – free from financial conflicts of interest, and is collaborative. International teams of dedicated researchers pool their knowledge and scientific expertise to generate results that could not be achieved by a single laboratory or scientist.

According to the results already reached by CMSRI funded scientists and others concerned about aluminum toxicity, avoiding this toxin may prevent a wide array of health conditions for which other causes have not been conclusively identified. For more information, check out the video on YouTube.

Read More

Clinicians Becoming Reluctant To Recommend HPV Vaccine

The Centers for Disease Control (CDC), recommends the HPV vaccination for the prevention of Human Papillomavirus, an infection said to be responsible for cervical cancer. However, clinicians are beginning to recommend the vaccination less often to patients and parents alike.

In a recent study, the most commonly cited reasons given by parents for not vaccinating their children was their lack of knowledge and their belief that the vaccine was unnecessary.

…..22.8% of parents with adolescent boys and 13% of parents with adolescent girls said that the lack of recommendation from their clinician was the main reason for no HPV vaccination.’

According to The President’s Cancer Panel, only 54% of girls between the ages thirteen and seventeen, received the HPV vaccination in 2012 and the number is even lower for boys, at 21%. The panel discovered that less than 33% of girls and 7% of boys fulfilled all three vaccine recommendations, far less than the government’s goal of having 80% of adolescents HPV vaccinated.

With the overwhelming amount of recent research refuting the beneficial claims of HPV vaccines, clinicians may be taking a step back due to the lack of information about long-term side effects.

According to one article, there is clinical evidence that the probability of having a serious adverse reaction from the HPV vaccination may exceed the likelihood of getting cancer due to presence of the HPV virus.

Many researchers funded by Children’s Medical Safety Research Institute, have found numerous cases of adverse reactions to various vaccines including the HPV vaccine because manufacturers continue to use aluminum as an ingredient.

Although, many in the medical community continue to argue that vaccination benefits outweigh the risks of adverse reactions, they cannot disprove research completed on the topic.

While the CDC and the FDA continue to promote vaccines and attempt to push clinicians to recommend them, the knowledge and information regarding negative effects will increase.

 

Read More

High Aluminum Content in Infant Formulas

formulaAccording to UNICEF, over 130 million babies are born each year worldwide, which means all those parents must start caring for their new children. The most basic care of a newborn involves the nutrition it receives in the form of breast milk or baby formula. While the numbers are not concrete, we can safely estimate that there are millions of infants who receive formula instead of natural breast milk. With that being said, can every caregiver trust the formula?

Infant formula is specifically constructed with ingredients that are essential for healthy development; however, some ingredients have made their way into some formulas which aren’t essential for development. Dr. Christopher Exley, a funded CMSRI researcher, found aluminum in both ready-to-drink milks and milk powders across 30 different infant formula products. While at first this may not seem unsettling, aluminum is a non-essential metal in the body and is consider a neurotoxic. So why is aluminum an ingredient in baby formula?

{Read The Full Study Here}

Some research has already suggested that aluminum can pose chronic health risks and is typically found in numerous vaccines. Studies have pointed out strong evidence that aluminum disrupts neurological development leading to conditions like Autism, Crohns Disease and even some cancers. Dr. Exley collected 30 samples of infant formula that can be regularly purchased from retailers in the UK. During the study, each sample was stored according to the manufacturers’ instruction and was tested immediately upon opening.

What raises concern is the amount of concentrated aluminum found in the formulas. According to European Union standards, drinking water may have up to 50 μg/L of concentrated aluminum and all 30 samples of infant formula had at least double the amount of concentrated aluminum in their servings. This raises concern over the health risks newborns are exposed to when consuming such formulas. Children, especially infants, are extremely sensitive to foreign chemicals and ingredients in their bodies and knowing that aluminum is a neurotoxic, it could potentially cause health problems.

Taking the 30 samples of infant formula and their results, it should raise awareness to the public that manufacturers are potentially causing ill effects to their children. This should call to action legislation, regulatory mandates and consumer advocacy campaigns to reduce the amount of aluminum found in infant formula.

Read More

Children At Risk: Aluminum Adjuvants

With over 80 years of use, the safety of aluminum adjuvants used in vaccines continues to rest on assumptions rather than scientific evidence. To date, a minimal amount of scientific evidence or research has been conducted regarding the safety of vaccines and the ingredients that come with them. That being said, recent research has shown pediatric populations suffer from unknown adverse reactions that stem from the toxicity of aluminum adjuvants.

Evidence that is available draws the conclusion that long-term persistence of aluminum adjuvants in adults can lead to cognitive dysfunction and autoimmunity. This raises the question – how does its use affect developing children? Since children and adults receive the same vaccines with the same dosage, children continue to be regularly exposed to much higher levels of aluminum adjuvants than adults because of their smaller and unique body structure.

Christopher Shaw and Lucija Tomljenovic are funded researchers of Children’s Medical Safety Research Institute and have drawn concerns regarding the use of neurotoxic substances such as aluminum as an adjuvant in pediatric vaccine formulations. The researchers urge that infants and young children should not be considered “small adults” when it comes to toxicological risks. The use of the same vaccinations should cease because children are not fully developed. The inherent risks pose developmental concerns when injecting the aluminum adjuvants because it can manipulate the autoimmune system in negative ways.

They suggest that aluminum vaccines cause multifactorial stimulatory effects on the immune system that can result in antigenic compounds failure to launch adequate immune responses. Also, during prenatal and early postnatal development, the brain is extremely vulnerable to neurotoxic insults. The development is highly sensitive and exposure to the neurotoxins will have a permeable impact to vital living functions. In addition to the early developmental stages of children and infants, ‘the immature renal system of the neonates significantly compromises their ability to eliminate environmental toxicants.’

This research should be enough evidence that children are at a higher risk of adverse reactions from aluminum adjuvants than adults. Infants and children have a unique physiology compared to adults that makes them much more vulnerable to noxious environmental insults.

Read More

George Mason University Appoints Claire Dwoskin

Claire Dwoskin was appointed to the Board of Visitors at George Mason University in the beginning of June. The university is located in Fairfax, Virginia which holds a 16 member board that exercises its authority principally in policy-making and oversight.

Dwoskin, alongside three other new appointees, will serve a four-year term starting July 1, 2014 and ending June 30, 2018. The 16 members are appointed by the Governor of Virginia, Gov. Terry McAuliffe, and serve on a rotating basis. These members are the corporate and governing body of the university that work under the leadership of a rector, vice rector and secretary.

Some of the duties Dwoskin will be responsible for include setting tuition rates, approving the university’s budget and appointing the university president. Currently, George Mason University is home to approximately 21,000 undergraduate students and 12,000 graduate students.

The Board of Visitors was established at the university in April 1972 when the school became an independent institution and has since assisted with the operations of the university. Meetings of the Board of Visitors and its committees are open to the public, except in the case of executive sessions.

With Dwoskin’s background in funding scientific research into chronic health conditions among young children and the elderly, she may be able to provide guidance on the importance of academic research as both a stimulant to economic growth and as an important factor in understanding societal and economic trends. Her family foundation has funded highly accessed research through Children’s Medical Safety Research Institute. Specifically, CMSRI is funding research into the causal factors underlying the increases in the prevalence of previously rare disorders that are becoming more frequent, such as serious autoimmune health conditions and age related disorders in the nervous system.

CMSRI is focused on discovering changes in human exposures which may be a leading cause to chronic health conditions like immune, inflammatory and cognitive disorders in children and adults ranging from asthma to neurodevelopmental disorders. Understanding the root causes is the key to preventing these conditions, as well as in developing more effective treatments and cures. Knowledge obtained through academic research funded by her foundation will likely spark new medical and therapeutic advances as well as reduce costs associated with conditions that can be prevented.

A vast amount of research has been conducted regarding the use of vaccines and their effects on the body because it is believed that some ingredients spur adverse reactions. One ingredient used in many vaccines is aluminum – which, when used as an adjuvant, has the potential to be toxic and harmful to every organ system in the body. Ms. Dwoskin will continue to support CMSRI while fulfilling board duties at George Mason University.

Read More

Supporting Ground Breaking Research Achieves Results

The mission of the Dwoskin Family Foundation has always been focused on children’s health, scientific research and raising awareness of adverse reactions to vaccines. The foundation was co-founded by Claire Dwoskin, a child health activist, sponsor and trailblazer of a global  effort to address the increasing occurrence of  chronic illness and disability, including autoimmunity and age related neurological diseases.

Dwoskin is the founder of Children’s Medical Safety Research Institute (CMSRI) which provides funding for medical and scientific research  on vaccines and their ingredients. Some of the projects the institute has worked on involves the use of aluminum in vaccines. Aluminum is an experimentally demonstrated neurotoxin commonly used in vaccines and it is supposed to act as an exciting agent within the immune system.

The research points out that despite 90 years of widespread use of aluminum adjuvants, the agencies responsible for evaluating the safety of vaccines and their ingredients have not yet developed an adequate understanding about their mechanisms of action.  A significant issue is in the safety of an ingredient that medical science has limited knowledge of, and which  has shown surprisingly dangerous effects on health and ability. This research points out the harm in administering substances to children and adults without utilizing sufficiently rigorous research methods to support the safety of their inclusion in not one, but multiple vaccines administered throughout childhood. Current study designs do not assess vaccines or their ingredients for their cumulative or synergistic biological or genetic effects, or their reactivity with other substances humans are exposed to, such as glyphosate, a chemical in Roundup.

Specifically, aluminum vaccine adjuvants carry risks for autoimmunity, chronic brain inflammation and related neurological complications which may have profound and widespread negative health consequences. The research was conducted by  researchers, Dr. Lucija Tomljenovic,  and Dr. Christopher Shaw, a neuroscientist who are from the University of British Columbia in Canada. Dr. Shaw also serves as chair of the scientific advisory board at CMSRI.

In a previous study completed by Dr. Shaw, aluminum hydroxide injections were linked to motor deficits and motor neuron degeneration. This research was conducted originally to study the effects of aluminum adjuvants in anthrax and other vaccines which were used during the time of the Gulf War. Many veterans suffered from the multi-system disorder called Gulf War Syndrome (GWS). Those affected by GWS showed signs of neurological deficits including various cognitive dysfunctions and motor neuron disease.

The most likely culprit appeared to be aluminum hydroxide per the study’s conclusions, When the aluminum adjuvant was injected into mice, it resulted in motor neuron loss, motor weakness, cognitive impairments and impaired social and emotional behaviors. The mice displayed  comparable neurological deficits, cognitive dysfunctions and motor neuron disease from the same age and weight adjusted doses of aluminum hydroxide that were administered to GWS victims.

The research funded by the Dwoskin Family Foundation and now CMSRI can study vaccines for their potential causal relationships to chronic health problems that are  appearing  with increased frequency after exposure to vaccines and their toxic ingredients. Studying the effects helps  raise awareness and spread information about the harmful and adverse effects aluminum adjuvants and vaccines in general can have on the body.

Read More

CMSRI Funded Researchers Hosted in France

The Dwoskin Family Foundation has been pursuing autoimmune disease research in the area of vaccine safety and advocacy. The efforts to draw international attention and raise awareness to increasing incidences of chronic illnesses and disabilities relating to vaccine injections has been a main priority to the foundation.

In support of such research that provides new information focused around childhood health conditions, the Children’s Medical Safety Research Institute (CMSRI) offers funding to methodologically sound controlled scientific research on vaccines and their ingredients.

Four CMSRI funded researchers were called upon to present at a debate in Paris, France to discuss the lack of safety of vaccines and ingredients. The hearing and press conference is the first time a western governmental authority has called experts to testify about the adverse reactions to vaccines. The vaccine debate was presented in front of French Parliament, French Senate, health authorities, medical professionals and the public.

French government officials had many stakeholders involved at the conference that were for both sides of the debate to keep the discussions fair. There were a number of people who spoke about their adverse events after they were vaccinated; a panel of scientists and medical professionals also were in attendance to present their research regarding unsafe vaccines and ingredients as well as supporters of vaccines.

Four separate round table discussions occurred that were followed by open debates and public questioning. CMSRI funded researchers from around the globe presented various issues to the discussion board.

Professor Romain Gherardi was a part of the first round table and discussed the Bio-persistence and neuro-migration of aluminum adjuvant which is a key ingredient in vaccines. Gherardi, manager of the Center of Muscle Neuropathology at H. Mondor Hospital in France, was able to represent how far our funded research can travel.

Professor Yehuda Shoenfeld joined the first round table and shared findings of the autoimmune and inflammatory syndrome induced by adjuvants. Shoenfeld is the Director of the Center for Autoimmune Diseases at the Sheba Medical Center and Chairman of the 9th International Congress on Autoimmunity in Israel.

Professor Chris Exley, of Keele University in the United Kingdom, presented the toxicity of aluminum in humans in the first round table. During the second round table, Dr. Lucija Tomljenovic, of University of British Columbia located in Canada, went over vaccination against HPV and described the benefit and risk balance.

This was the first open discussion regarding the safety risks by vaccination possibly paving the way for other countries around the world to take a second look. CMSRI continues to discover new elements regarding adverse health conditions and raising awareness to broaden its reach.

Read More